USANA HEALTH SCIENCES, INC. Unrecorded Unconditional Purchase Obligation, to be Paid, Year One
USANA HEALTH SCIENCES, INC. (USNA) had Unrecorded Unconditional Purchase Obligation, to be Paid, Year One of $3.86 million as of 2026-01-03, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary · last filed 2026-03-16
- 2026-01-03: Unrecorded Unconditional Purchase Obligation, to be Paid, Year One $3.86M.
- 2024-12-28: Unrecorded Unconditional Purchase Obligation, to be Paid, Year One $6.75M.
- 2023-12-30: Unrecorded Unconditional Purchase Obligation, to be Paid, Year One $8.02M.
- 2022-12-31: Unrecorded Unconditional Purchase Obligation, to be Paid, Year One $7.16M.
| Period end | Unrecorded Unconditional Purchase Obligation, to be Paid, Year One |
|---|---|
| 2026-01-03 | $3.86M 10-K · filed 2026-03-16 |
| 2024-12-28 | $6.75M 10-K · filed 2026-03-16 |
| 2023-12-30 | $8.02M 10-K · filed 2025-03-12 |
| 2022-12-31 | $7.16M 10-K · filed 2024-02-27 |
| 2022-01-01 | $6.15M 10-K · filed 2023-02-28 |
| 2021-01-02 | $10.36M 10-K · filed 2022-03-01 |
| 2019-12-28 | $11.96M 10-K · filed 2021-03-02 |
| 2018-12-29 | $10.69M 10-K · filed 2020-02-25 |
| 2017-12-30 | $10.72M 10-K · filed 2018-02-28 |
| 2016-12-31 | $5.88M 10-K · filed 2017-03-01 |
| 2016-01-02 | $14.76M 10-K · filed 2016-03-01 |
| 2015-01-03 | $15.75M 10-K · filed 2015-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |